Human Epidermal Growth Factor Receptor 2 Quantification Using Computational Pathology to Identify Novel Biomarkers for Trastuzumab Deruxtecan–Treated Human Epidermal Growth Factor Receptor 2–Positive ...
Laboratory-based design verification testing (DVT) of combination products and medical devices must be performed to demonstrate that the device meets the performance requirements that were set in the ...
Automated quality control using rapid PCR assays is replacing 28-day culture tests, cutting biopharmaceutical lot release ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results